These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 31613694)

  • 21. Physicians, thou shalt ration: the necessary role of bedside rationing in controlling healthcare costs.
    Ubel PA
    Healthc Pap; 2001; 2(2):10-21. PubMed ID: 12811141
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Responding to family requests for nondisclosure: the impact of oncologists' cultural background.
    Chittem M; Butow P
    J Cancer Res Ther; 2015; 11(1):174-80. PubMed ID: 25879358
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Cancer and spirituality: the young oncologists' point of view].
    Postel-Vinay S; Dumont S; Marijon H
    Bull Cancer; 2009 Dec; 96(12):1265-72. PubMed ID: 19959418
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [New therapeutic strategies in oncology].
    Bohuon C
    Ann Pharm Fr; 2010 Jul; 68(4):203-4. PubMed ID: 20637352
    [No Abstract]   [Full Text] [Related]  

  • 25. Are We Ready to Include Organ-Impaired Patients in Oncology Trials? A Clinical Pharmacology Perspective on Recent Recommendations.
    Masters JC; Wiernik PH
    J Clin Pharmacol; 2018 Jun; 58(6):701-703. PubMed ID: 29663409
    [No Abstract]   [Full Text] [Related]  

  • 26. Personalised medicine in paediatric oncology: Ethical practice outside the clinical trial framework?
    Hansford JR
    J Paediatr Child Health; 2019 Jan; 55(1):10-12. PubMed ID: 30499210
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The High Cost of New Cancer Therapies-A Challenge of Inequality for All Countries.
    Røe OD
    JAMA Oncol; 2017 Sep; 3(9):1169-1170. PubMed ID: 28033441
    [No Abstract]   [Full Text] [Related]  

  • 28. Unintended Consequences of the Right to Try Act for Palliative Care in Pediatric Oncology.
    Lanzel AF; Lavery JV
    JAMA Oncol; 2019 May; 5(5):603-604. PubMed ID: 30844025
    [No Abstract]   [Full Text] [Related]  

  • 29. Toward improved understanding of the ethical and clinical issues surrounding mandatory research biopsies.
    Peppercorn J
    J Clin Oncol; 2013 Jan; 31(1):1-2. PubMed ID: 23129739
    [No Abstract]   [Full Text] [Related]  

  • 30. Expanded Access and Right To Try Requests: The Community Oncologist's Experience.
    Zettler ME; Jeune-Smith Y; Feinberg BA; Phillips EG; Gajra A
    JCO Oncol Pract; 2021 Nov; 17(11):e1719-e1727. PubMed ID: 33886355
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Informing prospective research subjects of the influence of regulatory requirements for drug approval on the design of clinical trials in oncology.
    Markman M
    Cancer; 2007 Mar; 109(6):1003-6. PubMed ID: 17311306
    [No Abstract]   [Full Text] [Related]  

  • 32. Medical oncologists' participation in cancer clinical trials.
    Spaight SJ; Nash S; Finison LJ; Patterson WB
    Prog Clin Biol Res; 1984; 156():49-61. PubMed ID: 6473452
    [No Abstract]   [Full Text] [Related]  

  • 33. Cancer, access to investigational drugs, and patient rights in the U.S.A. and India.
    Sheehan HE
    Indian J Med Ethics; 2008; 5(4):170-2; discussion 173. PubMed ID: 18988376
    [No Abstract]   [Full Text] [Related]  

  • 34. Physician perspectives on compassionate use in pediatric oncology.
    Moerdler S; Zhang L; Gerasimov E; Zhu C; Wolinsky T; Roth M; Goodman N; Weiser DA
    Pediatr Blood Cancer; 2019 Mar; 66(3):e27545. PubMed ID: 30408307
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The significance of the concept of disease for justice in health care.
    Schramme T
    Theor Med Bioeth; 2007; 28(2):121-35. PubMed ID: 17516147
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of Oncologists' Attitudes Toward End-of-Life Care on Patients' Access to Palliative Care.
    Hui D; Cerana MA; Park M; Hess K; Bruera E
    Oncologist; 2016 Sep; 21(9):1149-55. PubMed ID: 27412394
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The murky world of disclosures.
    Sidaway P
    Nat Rev Clin Oncol; 2018 Nov; 15(11):651. PubMed ID: 30262918
    [No Abstract]   [Full Text] [Related]  

  • 38. RE: "I Think It's Been Met With a Shrug:" Oncologists' Views Toward and Experiences With Right-to-Try.
    Martani A; Tomasi M; Casonato C
    J Natl Cancer Inst; 2021 Mar; 113(3):338-339. PubMed ID: 33252658
    [No Abstract]   [Full Text] [Related]  

  • 39. Oncologists' and pediatric oncologists' perspectives and challenges for fertility preservation.
    Lampic C; Wettergren L
    Acta Obstet Gynecol Scand; 2019 May; 98(5):598-603. PubMed ID: 30714120
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The ethics of phase 0 oncology trials.
    Abdoler E; Taylor H; Wendler D
    Clin Cancer Res; 2008 Jun; 14(12):3692-7. PubMed ID: 18559585
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.